论文部分内容阅读
目的探讨低分子肝素对早发型重度子痫前期的疗效。方法将50例患者随机分为治疗组与对照组,每组25例,对照组予以常规治疗,治疗组在对照组基础上予以低分子肝素治疗,观察两组患者治疗前后的症状及体征变化,比较疗效。结果治疗组在降低D-二聚体方面明显优于对照组(P<0.05),在孕周延长时间方面明显优于对照组(P<0.05),在PLT、PT、APTT方面差异无统计学意义(P>0.05)。结论低分子肝素治疗早发型重度子痫前期安全有效,值得推广。
Objective To investigate the effect of low molecular weight heparin on early onset severe preeclampsia. Methods Fifty patients were randomly divided into treatment group and control group, with 25 cases in each group. The control group was treated routinely. The treatment group was treated with LMWH on the basis of the control group. The symptoms and signs of the two groups were observed before and after treatment. More effective. Results The treatment group was significantly better than the control group (P <0.05) in reducing D-dimer and prolonged gestational age (P <0.05), but there was no significant difference in PLT, PT, APTT Significance (P> 0.05). Conclusion Low molecular weight heparin is safe and effective in the treatment of early-onset severe preeclampsia and is worth promoting.